Literature DB >> 28351563

Sensitivity of tumor surface brushings to detect human papilloma virus DNA in head and neck cancer.

Barbara Kofler1, Wegene Borena2, Claudia Manzl3, Jozsef Dudas4, Anne-Sophie Wegscheider3, Pidder Jansen-Dürr5, Volker Schartinger4, Herbert Riechelmann4.   

Abstract

OBJECTIVE: Human papilloma virus (HPV) induced head and neck squamous cell carcinoma (HNSCC) represents a distinct tumor subset. We questioned how accurately a brushing from the tumor surface detects HPV in patients with HNSCC.
MATERIALS AND METHODS: Brushings from the tumor surface were compared with HPV DNA isolation from formalin-fixed and paraffin-embedded (FFPE) tumor biopsies, which served as the reference standard. In both matrices, HPV DNA was detected using a commercially available test kit. In addition, p16 was assessed in tumor biopsies by immunohistochemistry (IHC). The tumors were considered p16 positive if 70% or more of cancer cells expressed p16.
RESULTS: 93 patients with HNSCC were included. Sensitivity and specificity of the brush test were 83% (95%CI: 67-92%) and 85% (95%CI: 72-93%). Results of p16 IHC were concordant with FFPE samples DNA determinations in 73/93 patients. In 53 patients (57%) the tumor was located in the oropharynx and in 40 patients (43%) the tumor was located in the non-oropharynx region. Sensitivity and specificity of the brush test in patients with oropharyngeal cancer was higher with 86% (95%CI: 70-95%) and 89% (95%CI: 65-99%).
CONCLUSION: Superficial brushes from the tumor surface may be used to identify HPV positive HNSCC.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Brush test; Head and neck cancer; Human papillomavirus; p16

Mesh:

Substances:

Year:  2017        PMID: 28351563     DOI: 10.1016/j.oraloncology.2017.02.013

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  6 in total

1.  Persistent Head and Neck Cancer Following First-Line Treatment.

Authors:  Teresa Bernadette Steinbichler; Madeleine Lichtenecker; Maria Anegg; Daniel Dejaco; Barbara Kofler; Volker Hans Schartinger; Maria-Therese Kasseroler; Britta Forthuber; Andrea Posch; Herbert Riechelmann
Journal:  Cancers (Basel)       Date:  2018-11-03       Impact factor: 6.639

2.  Surgical rescue for persistent head and neck cancer after first-line treatment.

Authors:  Teresa Bernadette Steinbichler; L Golm; D Dejaco; D Riedl; B Kofler; C Url; D Wolfram; H Riechelmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-25       Impact factor: 2.503

3.  Post-Treatment HPV Surface Brushings and Risk of Relapse in Oropharyngeal Carcinoma.

Authors:  Barbara Kofler; Wegene Borena; Jozsef Dudas; Veronika Innerhofer; Daniel Dejaco; Teresa B Steinbichler; Gerlig Widmann; Dorothee von Laer; Herbert Riechelmann
Journal:  Cancers (Basel)       Date:  2020-04-25       Impact factor: 6.639

4.  Nerve Growth Factor (NGF)-Receptor Survival Axis in Head and Neck Squamous Cell Carcinoma.

Authors:  József Dudás; Wolfgang Dietl; Angela Romani; Susanne Reinold; Rudolf Glueckert; Anneliese Schrott-Fischer; Daniel Dejaco; Lejo Johnson Chacko; Raphaela Tuertscher; Volker Hans Schartinger; Herbert Riechelmann
Journal:  Int J Mol Sci       Date:  2018-06-14       Impact factor: 5.923

5.  The Role of HPV and Non-HPV Sexually Transmitted Infections in Patients with Oropharyngeal Carcinoma: A Case Control Study.

Authors:  Barbara Kofler; Johannes Laimer; Emanuel Bruckmoser; Teresa B Steinbichler; Annette Runge; Volker H Schartinger; Dorothee von Laer; Wegene Borena
Journal:  Cancers (Basel)       Date:  2020-05-08       Impact factor: 6.639

6.  KLF4, Slug and EMT in Head and Neck Squamous Cell Carcinoma.

Authors:  Julia Ingruber; Dragana Savic; Teresa Bernadette Steinbichler; Susanne Sprung; Felix Fleischer; Rudolf Glueckert; Gabriele Schweigl; Ira-Ida Skvortsova; Herbert Riechelmann; József Dudás
Journal:  Cells       Date:  2021-03-03       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.